Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00383929
Status:
COMPLETED
Last Update Posted:
2008-03-20
First Post:
2006-10-03
Brief Title:
Antihypertensive Efficacy and Safety of CandesartanHCT 32125 and 3225 mg in Comparison With Candesartan 32 mg
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2007-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-03
First Submit QC Date:
October 3 2006
Study First Post Date:
2006-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-19
Last Update Post Date:
2008-03-20
Last Update Post Date Type:
ESTIMATED